DRUG · Unmapped registry intervention
Iloprost PD-6
Find medicine records ·
Find other trials using this name
Clinical trial
The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc-15 Setting
NCT00467896
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Iloprost PD-15
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedThe "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc-15 Setting
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Iloprost PD-6DRUG
Iloprost PD-15DRUG
Sponsors & collaborators
Actelionlead sponsor
Mapped research locations
New YorkNew York, United States2HoustonTexas, United States1BaltimoreMaryland, United States1San AntonioTexas, United States1PittsburghPennsylvania, United States1DurhamNorth Carolina, United States1PhoenixArizona, United States1New OrleansLouisiana, United States1La JollaCalifornia, United States1MilwaukeeWisconsin, United States1Iowa CityIowa, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00467896 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.